Anixa Biosciences, Inc. (ANIX) Insider Trading Activity
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $57M |
ANIX Insider Trading Activity
ANIX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $445,192 | 20 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Titterton Lewis H jr | director | 14 | $224,531 | 0 | $0 | $224,531 |
| KUMAR AMIT | Chief Executive Officer | 2 | $156,140 | 0 | $0 | $156,140 |
| Catelani Michael | President, COO, & CFO | 2 | $34,971 | 0 | $0 | $34,971 |
| Baskies Arnold M | director | 2 | $29,550 | 0 | $0 | $29,550 |
About Anixa Biosciences, Inc.
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Insider Activity of Anixa Biosciences, Inc.
Over the last 12 months, insiders at Anixa Biosciences, Inc. have bought $445,192 and sold $0 worth of Anixa Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Anixa Biosciences, Inc. have bought $576,631 and sold $42,126 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Titterton Lewis H jr (director) — $224,531. KUMAR AMIT (Chief Executive Officer) — $156,140. Catelani Michael (President, COO, & CFO) — $34,971.
The last purchase of 5,000 shares for transaction amount of $14,100 was made by Baskies Arnold M (director) on 2025‑01‑28.
List of Insider Buy and Sell Transactions, Anixa Biosciences, Inc.
| 2025-01-28 | Baskies Arnold M | director | 5,000 0.0156% | $2.82 | $14,100 | +1.61% | ||
| 2025-01-24 | Titterton Lewis H jr | director | 1,000 0.0033% | $3.00 | $3,000 | +0.71% | ||
| 2025-01-23 | Titterton Lewis H jr | director | 2,000 0.0062% | $2.91 | $5,820 | -2.74% | ||
| 2025-01-22 | Titterton Lewis H jr | director | 2,000 0.0064% | $3.01 | $6,020 | -4.70% | ||
| 2025-01-21 | Titterton Lewis H jr | director | 6,000 0.0176% | $2.59 | $15,540 | +1.07% | ||
| 2025-01-17 | Titterton Lewis H jr | director | 10,000 0.0331% | $2.57 | $25,700 | +17.84% | ||
| 2025-01-15 | KUMAR AMIT | Chief Executive Officer | 43,000 0.1284% | $2.23 | $95,890 | +24.12% | ||
| 2025-01-15 | Catelani Michael | President, COO, & CFO | 9,289 0.0267% | $2.15 | $19,971 | +24.12% | ||
| 2024-07-31 | Titterton Lewis H jr | director | 5,580 0.0182% | $3.23 | $18,023 | -8.13% | ||
| 2024-07-30 | Titterton Lewis H jr | director | 21,646 0.067% | $3.06 | $66,237 | -1.29% | ||
| 2024-07-26 | Titterton Lewis H jr | director | 7,700 0.0239% | $3.03 | $23,331 | 0.00% | ||
| 2024-07-26 | Baskies Arnold M | director | 5,000 0.0158% | $3.09 | $15,450 | 0.00% | ||
| 2024-07-25 | Titterton Lewis H jr | director | 796 0.0024% | $2.81 | $2,237 | +5.54% | ||
| 2024-06-14 | Titterton Lewis H jr | director | 4,000 0.0128% | $2.68 | $10,720 | +15.90% | ||
| 2024-06-13 | Titterton Lewis H jr | director | 405 0.0013% | $2.70 | $1,094 | +11.03% | ||
| 2024-06-11 | Titterton Lewis H jr | director | 7,102 0.0225% | $2.66 | $18,891 | +15.27% | ||
| 2024-06-10 | Titterton Lewis H jr | director | 330 0.001% | $2.60 | $858 | +12.92% | ||
| 2024-06-07 | Titterton Lewis H jr | director | 10,738 0.0332% | $2.52 | $27,060 | +18.04% | ||
| 2024-06-07 | KUMAR AMIT | Chief Executive Officer | 25,000 0.0738% | $2.41 | $60,250 | +18.04% | ||
| 2024-06-07 | Catelani Michael | President, COO, & CFO | 6,250 0.0184% | $2.40 | $15,000 | +18.04% |
Insider Historical Profitability
| Titterton Lewis H jr | director | 933334 2.8988% | $2.38M | 72 | 1 | +3.83% |
| KUMAR AMIT | Chief Executive Officer | 559925 1.7391% | $1.43M | 54 | 1 | +9.12% |
| Baskies Arnold M | director | 120000 0.3727% | $306,000.00 | 11 | 0 | <0.0001% |
| Catelani Michael | President, COO, & CFO | 44500 0.1382% | $113,475.00 | 6 | 0 | +29.83% |
| KRUSOS DENIS A | Chief Executive Officer | 1969880 6.1182% | $5.02M | 1 | 0 | 0% |
| Stender Tisha | Chief Operating Officer | 800000 2.4847% | $2.04M | 1 | 0 | <0.0001% |
| JOHNSON BRUCE F | director | 419119 1.3017% | $1.07M | 68 | 0 | +8.83% |
| LAROUNIS GEORGE P | director | 320000 0.9939% | $816,000.00 | 1 | 0 | 0% |
| Roop John H. | Sr. Vice President-Engineering | 129500 0.4022% | $330,225.00 | 3 | 0 | <0.0001% |
| BERMAN ROBERT ANDREW | President & CEO | 61553 0.1912% | $156,960.15 | 26 | 0 | +9.15% |
| MONAHAN JOHN J | director | 50900 0.1581% | $129,795.00 | 1 | 0 | <0.0001% |
| Gottschalk Emily | director | 45665 0.1418% | $116,445.75 | 3 | 0 | <0.0001% |
| WILLIAMS RICHARD H | director | 25000 0.0776% | $63,750.00 | 0 | 1 | |
| HERMS HENRY P | V.P., Finance & CFO | 22125 0.0687% | $56,418.75 | 1 | 15 | 0% |
| Cavalier David | director | 2000 0.0062% | $5,100.00 | 1 | 0 | <0.0001% |
| DISANTO FRANK J | President | 0 0% | $0 | 0 | 10 |
Historical Insider Profitability vs. Competitors
Anixa Biosciences, Inc. (ANIX) | $4,968,419 | 139 | 5.13% | $82.1M |
$2,600,095 | 110 | 13.50% | $73.75M | |
$49,091,668 | 110 | 13.11% | $86.15M | |
$22,608,361 | 93 | 3.94% | $82.13M | |
$671,363 | 44 | -16.23% | $85.23M | |
$53,912,175 | 35 | -8.02% | $74.36M | |
$144,247,213 | 29 | 10.15% | $87.16M | |
$26,678,853 | 21 | -5.95% | $72.44M | |
$245,302 | 15 | -4.08% | $70.87M | |
$14,562,799 | 14 | -4.77% | $76.35M | |
$135,589,307 | 10 | 32.46% | $85.46M | |
$15,724,108 | 9 | 124.63% | $72.86M | |
$299,343 | 6 | -44.75% | $76.16M | |
$272,982 | 6 | -28.53% | $86.02M | |
$45,000,000 | 6 | -31.22% | $87.17M | |
$4,256,958 | 4 | 22.95% | $70.29M | |
$4,249,999 | 4 | 5.44% | $72.39M | |
$401,951 | 4 | 57.41% | $87.8M | |
$40,000,000 | 3 | -16.24% | $83.97M |
ANIX Institutional Investors: Active Positions
| Increased Positions | 23 | +36.51% | 588,395 | +10.6% |
| Decreased Positions | 16 | -25.4% | 195,453 | -3.52% |
| New Positions | 12 | New | 263,484 | New |
| Sold Out Positions | 6 | Sold Out | 89,158 | Sold Out |
| Total Postitions | 70 | +11.11% | 6M | +7.08% |
ANIX Ownership Change vs Market
Institutional Investor Ownership
| Vanguard Group Inc | $3,872.00 | 4.35% | 1.39M | 0 | 0% | 2024-12-31 |
| Laird Norton Wetherby Trust Company, Llc | $1,730.00 | 1.94% | 622,235 | +1,500 | +0.24% | 2024-12-31 |
| D.A. Davidson & Co. | $1,708.00 | 1.92% | 614,272 | -56,800 | -8.46% | 2025-03-31 |
| Ubs Group Ag | $1,485.00 | 1.67% | 534,124 | +4,726 | +0.89% | 2024-12-31 |
| Mission Wealth Management, Lp | $1,305.00 | 1.47% | 469,517 | 0 | 0% | 2025-03-31 |
| Geode Capital Management, Llc | $916.00 | 1.03% | 329,377 | +599 | +0.18% | 2024-12-31 |
| Susquehanna International Group, Llp | $783.00 | 0.88% | 281,693 | +185,345 | +192.37% | 2024-12-31 |
| Bank Of America Corp /De/ | $585.00 | 0.66% | 210,257 | -6,891 | -3.17% | 2024-12-31 |
| Blackrock, Inc. | $543.00 | 0.61% | 195,423 | +12,391 | +6.77% | 2025-03-31 |
| Long Focus Capital Management, Llc | $410.00 | 0.46% | 147,360 | -18,341 | -11.07% | 2024-12-31 |